Navigation Links
Prostate cancer community calls for better early detection and treatment
Date:9/17/2010

Washington, DC In a presentation today at the Congressional Black Caucus Foundation's Annual Legislative Conference Health Braintrust meeting, Faina Shtern, M.D., president and CEO of AdMeTech Foundation, unveiled overwhelming support from Congressional Black Caucus (CBC) members and patient advocacy organizations for the Prostate Research, Imaging, and Men's Education Act of 2010 (PRIME Act). This support builds on the rapidly growing number of Congressional co-sponsors for the legislation, including 25 CBC members who are particularly concerned about the disproportionate impact of prostate cancer on African American men.

Prostate cancer is the most common and the second-most lethal cancer in American men. African American men have a 60 percent higher incidence and 250 percent higher mortality rate.

Reintroduced earlier this year by Rep. Elijah Cummings (D-Md.), former CBC chair and long-time champion of the fight against prostate cancer, the PRIME Act would provide $650 million over five years for research and education to advance prostate cancer diagnostics. Rep. Cummings reintroduced the bill following a House Oversight and Government Reform Committee that identified the need for reliable blood or urinary tests for mass screening and medical imaging technologies for improved early detection and treatment. Sen. Barbara Boxer (D-Calif.) has introduced similar legislation in the Senate.

"Despite the tragic statistics surrounding prostate cancer, there are no reliable, accurate diagnostic tools for the detection and treatment of the disease," said Rep. Cummings. "We must allow patients to make informed decisions. I am concerned that many men will not bother to have the initial discussion with their physician because of new reports that current screening will not make a difference in their overall health."

The PRIME Act has seen growing momentum from all sectors of the prostate cancer community, formally announced today by Dr. Shtern. In her presentation, Dr. Shtern emphasized prostate cancer as "public health disaster" among African American men and discussed racial disparities in incidence and outcomes. She described emerging scientific data indicating that image-guided early detection may save lives, and that image-guided treatment can control prostate cancer, as well as radical surgery, while drastically reducing complications and costs.

"The PRIME Act will serve as a 'Manhattan Project' for ending the prostate cancer as a socio-economic crisis in our country and a public health disaster among African American men. This legislation will enable development of lifesaving tools for mass screening and advancement of imaging technologies to guide early detection and minimally-invasive treatment," said Dr. Shtern. "The PRIME Act is particularly timely now, as President Obama named September National Prostate Cancer Awareness Month and urged research for improved prevention, early detection and treatment."

The prostate cancer advocacy community also unfolded a united push for the legislation today. Dr. Shtern announced and released formal letters of support for the PRIME Act on behalf of the Men's Health Network, Mets Mavericks, National Alliance of State Prostate Cancer Coalitions, Prostate Health Education Network, Prostate Cancer Research Institute (PCRI), Prostate Cancer International, Patient Advocates for Advanced Cancer Treatments, Us TOO International Prostate Cancer Education and Support Network and Zero: The Project to End Prostate Cancer. In addition, three major professional medical organizations the Academy of Radiology Research, Medical Imaging Technology Association and the Radiologic Society of North America also announced their support for the PRIME Act.

"Research to advance diagnostic and imaging technologies will make it possible to end a staggering extent of unnecessary and failed procedures," said Mark Scholz, M.D., head of PCRI, medical director of Prostate Oncology Specialists in Los Angeles, assistant professor of medicine at the University of Southern California and author of the recently published book, Invasion of the Prostate Snatchers. In his book, Dr. Scholz argues that forty out of the fifty thousand radical surgeries performed annually are unjustified, and that these men would have benefited more from non-invasive monitoring of their prostate cancer.


'/>"/>

Contact: Jenna Langer
jlanger@powelltate.com
202-585-2146
Powell Tate
Source:Eurekalert

Related medicine news :

1. Advance Toward Test for Aggressive Prostate Cancer
2. DASH FOR DAD Race Series Coming to 11 Cities to Raise Prostate Cancer Awareness
3. Jim Huber to Serve as National Spokesman for Know Your Score: Fight Prostate Campaign at Myrtle Beach Golf Holiday in August
4. Few differences in outcomes between open and laparoscopic prostate surgery
5. Two Surgical Methods Equally Successful for Prostate Cancer
6. Genetic Mutation Linked to Prostate Cancer in Blacks
7. Statins May Benefit Prostate Cancer Patients
8. Demand For Mobile Prostate Cancer Brachytherapy Vendor Programs Continues Into 2010
9. Be a Star Athlete in the Fight Against Prostate Cancer
10. Do men with early prostate cancer commit suicide more frequently?
11. Effective prostate cancer treatment discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: